New hope for rare VEXAS syndrome: drug trial targets inflammation
NCT ID NCT07098936
First seen Jan 07, 2026 · Last updated May 14, 2026 · Updated 22 times
Summary
This study tests a drug called momelotinib in 57 adults with VEXAS syndrome, a rare inflammatory disease that often requires high-dose steroids. The goal is to see if momelotinib can control symptoms and allow lower steroid doses. Participants will take the drug daily, and doctors will check their response over 24 weeks.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MYELO DYSPLASTIC SYNDROME are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
CH Lyon sud - Service d'Hématologie Clinique
RECRUITINGPierre-Bénite, 69495, France
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
-
CHU Estaing - Service d'Hématologie Clinique
NOT_YET_RECRUITINGClermont-Ferrand, 63000, France
Contact Email: •••••@•••••
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
-
CHU Nantes - Hôtel Dieu - Service d'Hématologie Clinique
NOT_YET_RECRUITINGNantes, 44093, France
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
-
CHU d'Angers - Service des Maladies du sang
NOT_YET_RECRUITINGAngers, 49933, France
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
-
CHU de Haut-Lévèque - Centre F. Magendie - Service des Maladies du sang
NOT_YET_RECRUITINGPessac, 33604, France
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
-
CHU de Tours - Hôpital Bretonneau - Service de Médecine Interne
NOT_YET_RECRUITINGTours, 37044, France
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
-
Hôpital Claude Huriez - Service de Médecine Interne
NOT_YET_RECRUITINGLille, 59037, France
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
-
Hôpital Pontchaillou Service d'hématologie clinique et service de médecine interne
NOT_YET_RECRUITINGRennes, 35033, France
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
-
Hôpital Saint Louis - Service hématologie séniors
NOT_YET_RECRUITINGParis, 75010, France
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
-
Hôpital Saint-Antoine - Service de Médecine Interne
NOT_YET_RECRUITINGParis, 75012, France
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
-
IUCT Oncopole Département d'hématologie / Unité de médecine interne
NOT_YET_RECRUITINGToulouse, 31059, France
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Conditions
Explore the condition pages connected to this study.